Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2017 | 03-2017 | 12-2016 | 09-2016 | 06-2016 | |
| Sales | 381 | 390 | 1,085 | 1,499 | 1,266 |
| Cost of Goods | 5 | 57 | -20 | 58 | 95 |
| Gross Profit | 376 | 333 | 1,105 | 1,441 | 1,171 |
| Operating Expenses | 8,945 | 11,652 | 12,336 | 11,054 | 15,669 |
| Operating Income | -8,564 | -11,262 | -11,251 | -9,555 | -14,403 |
| Interest Expense | 413 | 306 | 372 | 167 | 76 |
| Other Income | -7,127 | 62,469 | 3,751 | 38,987 | 35,704 |
| Pre-tax Income | -16,104 | 50,901 | -7,872 | 29,265 | 21,225 |
| Income Tax | -3,877 | 3,877 | N/A | 0 | 0 |
| Net Income Continuous | -12,227 | 47,024 | -7,872 | 29,265 | 21,225 |
| Minority Interests | -576 | -2,264 | -2,808 | -1,934 | -3,324 |
| Net Income | $-11,651 | $49,288 | $-5,064 | $31,199 | $24,549 |
| EPS Basic Total Ops | -0.11 | 0.46 | -0.02 | 0.30 | 0.26 |
| EPS Basic Continuous Ops | -0.11 | 0.44 | -0.06 | 0.28 | 0.23 |
| EPS Diluted Total Ops | -0.11 | 0.46 | -0.03 | 0.30 | 0.26 |
| EPS Diluted Continuous Ops | -0.11 | 0.44 | -0.05 | 0.28 | 0.22 |
| EBITDA(a) | $-7,390 | $-10,191 | $-11,432 | $-7,454 | $-12,926 |